• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血液透析期间预测药物清除率的简易公式。

Simple Formula for Predicting Drug Removal Rates During Hemodialysis.

作者信息

Urata Motoki, Narita Yuki, Fukunaga Masaki, Kadowaki Daisuke, Hirata Sumio

机构信息

Center for Clinical Pharmaceutical Sciences, Division of Clinical Pharmacology, Faculty of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.

Laboratory of Clinical Pharmaceutics, Faculty of Pharmaceutical Sciences, Sojo University, Kumamoto, Japan.

出版信息

Ther Apher Dial. 2018 Oct;22(5):485-493. doi: 10.1111/1744-9987.12675. Epub 2018 Jul 10.

DOI:10.1111/1744-9987.12675
PMID:29987905
Abstract

The present study sought to derive a simple formula for predicting the drug removal rates during hemodialysis. We examined the relationship between drug removal rates during hemodialysis and the molecular weights or pharmacokinetic parameters of injectable drugs (N = 90) obtained from pharmaceutical interview forms in Japan. Stepwise multiple regression analysis with the removal rate by hemodialysis as the objective variable adjusted for molecular weight or pharmacokinetic parameters as explanatory variables, showed that the logarithm of molecular weight (B = -18.87), the protein binding rate (B = -0.40), and the fraction of the unchanged drug excreted into the urine/volume of distribution (B = 0.05) were significantly and independently associated with drug removal rate by hemodialysis (α = 90.78, adjusted R  = 0.64, P = 2.2e ). Our data demonstrated that molecular weight, protein binding rate, and volume of distribution were important factors affecting drug removal during hemodialysis, and that our simple regression equation could be used to predict the drug removal rate during hemodialysis.

摘要

本研究旨在推导一个预测血液透析期间药物清除率的简单公式。我们研究了日本从药学访谈表中获取的可注射药物(N = 90)的血液透析期间药物清除率与分子量或药代动力学参数之间的关系。以血液透析清除率为目标变量,以分子量或药代动力学参数为解释变量进行逐步多元回归分析,结果显示分子量的对数(B = -18.87)、蛋白结合率(B = -0.40)以及原形药物经尿液排泄的分数/分布容积(B = 0.05)与血液透析药物清除率显著且独立相关(α = 90.78,调整后R = 0.64,P = 2.2e)。我们的数据表明,分子量、蛋白结合率和分布容积是影响血液透析期间药物清除的重要因素,且我们的简单回归方程可用于预测血液透析期间的药物清除率。

相似文献

1
Simple Formula for Predicting Drug Removal Rates During Hemodialysis.血液透析期间预测药物清除率的简易公式。
Ther Apher Dial. 2018 Oct;22(5):485-493. doi: 10.1111/1744-9987.12675. Epub 2018 Jul 10.
2
Improved Formula for Predicting Hemodialyzability of Intravenous and Oral Drugs.改良的预测静脉内和口服药物血液透析能力的公式。
Blood Purif. 2021;50(6):865-875. doi: 10.1159/000513152. Epub 2021 Mar 9.
3
Application of a hemodialysis clearance prediction model using quantitative structure-pharmacokinetic relationship analysis.应用定量构效关系分析的血液透析清除预测模型。
Ther Apher Dial. 2020 Dec;24(6):655-667. doi: 10.1111/1744-9987.13472. Epub 2020 Feb 3.
4
Effect of plasma protein binding, volume of distribution and molecular weight on the fraction of drugs eliminated by hemodialysis.血浆蛋白结合、分布容积和分子量对血液透析清除药物分数的影响。
Clin Nephrol. 1983 Apr;19(4):201-5.
5
Drug Distribution Part 2. Predicting Volume of Distribution from Plasma Protein Binding and Membrane Partitioning.药物分布 第2部分:根据血浆蛋白结合和膜分配预测分布容积
Pharm Res. 2017 Mar;34(3):544-551. doi: 10.1007/s11095-016-2086-y. Epub 2016 Dec 13.
6
In vivo evaluation of drug dialyzability in a rat model of hemodialysis.在血液透析大鼠模型中评估药物透析性能的体内评价。
PLoS One. 2020 Jun 12;15(6):e0233925. doi: 10.1371/journal.pone.0233925. eCollection 2020.
7
Drug removal during continuous hemofiltration or hemodialysis.
Contrib Nephrol. 1991;93:110-6. doi: 10.1159/000420197.
8
Pharmacokinetic considerations in chronic kidney disease and patients requiring dialysis.慢性肾脏病及需要透析的患者的药代动力学考量
Expert Opin Drug Metab Toxicol. 2014 Aug;10(8):1131-43. doi: 10.1517/17425255.2014.931371. Epub 2014 Jun 24.
9
Plasma protein binding and distribution characteristics of drugs as indices of their hemodialyzability.作为药物血液透析性指标的血浆蛋白结合及分布特征。
Clin Pharmacol Ther. 1978 Aug;24(2):154-61. doi: 10.1002/cpt1978242154.
10
Drug dosing during intermittent hemodialysis and continuous renal replacement therapy : special considerations in pediatric patients.间歇性血液透析和连续性肾脏替代治疗期间的药物剂量:儿科患者的特殊考量
Paediatr Drugs. 2004;6(1):45-65. doi: 10.2165/00148581-200406010-00004.

引用本文的文献

1
Acute decompensated right heart failure potentially triggered by multiple factors including pulmonary vasodilator removal during plasma exchange: a case report.急性失代偿性右心衰竭可能由多种因素引发,包括血浆置换过程中肺血管扩张剂的撤除:一例病例报告。
JA Clin Rep. 2025 Jan 27;11(1):5. doi: 10.1186/s40981-025-00765-0.
2
Model-Informed Precision Dosing of Vancomycin in Adult Patients Undergoing Hemodialysis.模型指导下的血液透析成人患者万古霉素精准给药。
Antimicrob Agents Chemother. 2023 Jun 15;67(6):e0008923. doi: 10.1128/aac.00089-23. Epub 2023 May 17.
3
Case report: therapeutic monitoring of vancomycin in an acute liver failure patient with anuria under high-flow continuous hemodiafiltration.
病例报告:高流量持续血液透析滤过治疗下无尿急性肝衰竭患者万古霉素的治疗监测
J Pharm Health Care Sci. 2023 May 1;9(1):15. doi: 10.1186/s40780-023-00283-0.
4
Construction of a prediction model for drug removal rate in hemodialysis based on chemical structures.基于化学结构构建血液透析中药物清除率的预测模型。
Mol Divers. 2022 Oct;26(5):2647-2657. doi: 10.1007/s11030-021-10348-7. Epub 2022 Jan 1.
5
Ambrisentan use in a HIV-1 infected patient with end-stage renal disease and pulmonary hypertension: minimal removal by hemodialysis - a case report.安贝生坦在一名合并终末期肾病和肺动脉高压的 HIV-1 感染患者中的应用:血液透析极少清除-一例报告。
BMC Nephrol. 2020 Jan 28;21(1):24. doi: 10.1186/s12882-019-1659-5.